Novel Ribozyme Holds Promise for RNA Research and Therapeutics

Scientists at Julius-Maximilians-Universität (JMU) Würzburg, led by chemistry professor Claudia Höbartner, have unveiled a newly discovered ribozyme called SAMURI, offering new opportunities for RNA research and potential therapeutic applications. Their findings were published in Nature Chemistry.

Ribonucleic acid (RNA) molecules play diverse roles in cells, from transferring genetic information to regulating gene activity. Some RNA molecules, known as ribozymes, have catalytic properties similar to enzymes, enabling biochemical reactions that would otherwise be challenging or impossible. SAMURI is a recently identified ribozyme that precisely modifies other RNA molecules, making it valuable for RNA research and possible therapeutic applications in the future.

SAMURI's ability to modify RNA molecules with high precision is particularly useful in RNA research. Researchers can use ribozymes like SAMURI as tools to label RNA with dyes, making RNA pathways within cells and interactions with other molecules more visible and easier to study.

In addition to its applications in research, ribozymes like SAMURI hold potential for therapeutic use. They could be used when the natural enzymes responsible for specific tasks in cells are missing or non-functional due to genetic mutations.

What sets SAMURI apart is its ability to modify other RNA molecules at a precisely defined site, specifically targeting adenine. It attaches molecules that allow dyes or other compounds to be easily added, a process known as click chemistry. SAMURI is active under physiological conditions similar to those in living cells, making it a valuable tool for studying RNA within the cellular environment.

The research team plans to further investigate SAMURI's structure and mechanism of action. They also aim to develop additional ribozymes capable of modifying RNA building blocks other than adenine. These advancements in ribozyme technology have the potential to significantly impact RNA research and therapeutic interventions in the future.